SVB MoffettNathanson Upgrades Reata Pharmaceuticals (RETA) to Outperform
Tweet
Share
E-mailGet Alerts RETA Hot Sheet
Price: $172.36 --0%
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
SVB MoffettNathanson analyst Joseph P. Schwartz upgraded Reata Pharmaceuticals (NASDAQ: RETA) from Market Perform to Outperform with a price target of $115.00 (from $80.00).
For an analyst ratings summary and ratings history on Reata Pharmaceuticals click here. For more ratings news on Reata Pharmaceuticals click here.
Shares of Reata Pharmaceuticals closed at $93.80 yesterday.
You May Also Be Interested In
- New Street Research Upgrades Micron Technology (MU) to Buy
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
